Internship - Stem Cell Therapy Scientist Cryopreservation at Novo Nordisk
Fremont, CA
About the Job
About the Department
Novo Nordisk, a global health care company, is committed to discovering and developing innovative medicines to help people living with diabetes lead longer, healthier lives. To support this, Novo Nordisk is conducting research on stem cell therapy. Stem cell research raises hopes for improved treatment of Type 1 Diabetes and for future treatments with cell transplantation therapy. This treatment could be offered to people with many different serious chronic diseases caused by the degeneration of specific cells, such as Type 1 Diabetes. Type 1 Diabetes is manifested by the selective destruction of the insulin-producing cells in the body, which leads to a life-long dependence on insulin injections to control blood sugar levels. It is usually diagnosed in children and young adults. Cell therapy may offer a better treatment by replacing the lost cells with new insulin-producing cells derived from stem cells, thus avoiding daily multiple insulin injections as well as numerous blood glucose tests. This treatment may also offer better blood glucose control, which is crucial to avoid late-stage complications such as blindness and kidney failure. In this project Novo Nordisk will generate new stem cell lines to be used in future cell therapies to treat Type 1 Diabetes, Parkinson’s and chronical heart failure. Are you ready to make a difference?
The Program
At Novo Nordisk, interns will have the opportunity to work closely with experienced industry professionals and gain valuable, hands-on, full-time work experience. For ten working weeks, interns will be immersed in the environment of a global pharmaceutical company and contribute to the line of business by providing sustainable and meaningful project work. Our internship program also includes instructor led trainings, a leadership engagement series, and a guided mentorship program to offer professional and personal development.
Program Start: June 2nd, 2025
Program End: August 15th, 2025
Scope of Position
Our facility is at the forefront of stem cell technology, developing and producing cell therapeutic replacement therapies to treat conditions such as diabetes, heart failure, and Parkinson's dis-ease. Our group is working on cryopreservation of cell-therapy aggregates as part of a platform technology to enable the crucial transport and preservation of live cells, making cell therapy readily available to patients worldwide.
Intern responsibilities include but are not limited to:
Physical Requirements
0% overnight travel required.
Qualifications
At this time, Novo Nordisk is not currently hiring individuals for this position who now or in the future would require sponsorship for employment visa status.
The base compensation range for this position is $45,760 to $79,040 annualized. Base compensation is determined based on a number of factors. This position is not benefit eligible*
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.